MABINOVAN 100 MG TBL PRO 60X1
What is the maximum co-payment for MABINOVAN?
If the insurance company contributes, the maximum co-payment is 1 374,32 Kč. The maximum pharmacy price is 1 937,01 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 253,01 Kč.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does MABINOVAN have a counted co-payment set?
Yes, the medicine has a counted co-payment of 1 184,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
562,69 Kč.
Does the insurance company pay a higher amount in some cases?
Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 1 684,00 Kč.
Does the medicine have an indication restriction?
Rychlý přehled
| Dosage form | Tablets with prolonged release |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 1 374,32 Kč. Maximální cena: 1 937,01 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 2. 4. 2026. Výroba byla ukončena s platností od 2. 7. 2026. The manufacturer lists medicines with the following code as a potential substitute: 027026001845600269000 |
| Kód SÚKL | 0265072 |
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe MABINOVAN?
Prescription is not conditional on a medical specialization.
What is the composition of MABINOVAN?
. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found v lokální importní databázi.
Which medicines are similar to MABINOVAN?
The medicine belongs to ATC group N02AX06. Název skupiny není v lokální importní databázi dostupný.
Who manufactures MABINOVAN?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 2. 4. 2026. Production was terminated with effect from 2. 7. 2026. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for MABINOVAN?
The medicine has code 0265072. Code details can be found here.
How many packs of MABINOVAN were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of MABINOVAN were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 22. 06. 2026